Replies to post #751 on Evoke Pharma Inc. (EVOK)

[Snug Harbour]

Evoke Pharma Inc (NASDAQ: EVOK), a specialty pharmaceutical company that focuses on the development of drugs to treat gastrointestinal disorders and diseases, plummeted more than 75 percent in reaction to the company's announcement that a Phase III trial failed to achieve its primary endpoint.

https://finance.yahoo.com/news/importance-phase-iii-trials-135021880.html